Your browser doesn't support javascript.
loading
Peripheral Inflammatory Indexes Neutrophil/Lymphocyte Ratio (NLR) and Red Cell Distribution Width (RDW) as Prognostic Biomarkers in Advanced Solitary Fibrous Tumour (SFT) Treated with Pazopanib.
Hidalgo-Ríos, Samuel; Carrillo-García, Jaime; Moura, David S; Stacchiotti, Silvia; López-Pousa, Antonio; Redondo, Andrés; Italiano, Antoine; Gutiérrez, Antonio; Grignani, Giovanni; Hindi, Nadia; López-Guerrero, José-Antonio; Muro, Xavier García Del; Trufero, Javier Martínez; Palmerini, Emanuela; García, Ana Sebio; Bernabeu, Daniel; Le Cesne, Axel; Casali, Paolo Giovanni; Blay, Jean-Yves; Cruz Jurado, Josefina; Martin-Broto, Javier.
Afiliação
  • Hidalgo-Ríos S; Department of Clinical Pharmacology, University Hospital Virgen del Rocío, 41013 Sevilla, Spain.
  • Carrillo-García J; Health Research Institute Fundación Jiménez Díaz (IIS-FJD, UAM), 28040 Madrid, Spain.
  • Moura DS; Medical Oncology Department, University Hospital General de Villalba, 28400 Madrid, Spain.
  • Stacchiotti S; Health Research Institute Fundación Jiménez Díaz (IIS-FJD, UAM), 28040 Madrid, Spain.
  • López-Pousa A; Medical Oncology Department, University Hospital General de Villalba, 28400 Madrid, Spain.
  • Redondo A; Adult Mesenchymal and Rare Tumor Unit, Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
  • Italiano A; Department of Medical Oncology, 08041 Sant Pau Hospital, Barcelona, Spain.
  • Gutiérrez A; Department of Medical Oncology, University Hospital La Paz, Institute for Health Research (IdiPAZ), 28046 Madrid, Spain.
  • Grignani G; Department of Oncology, Institut Bergonié, 33000 Bordeaux, France.
  • Hindi N; Department of Hematology, University Hospital Son Espases, 07210 Palma, Spain.
  • López-Guerrero JA; Sarcoma Unit, Division of Medical Oncology, Candiolo Cancer Institute, 10060 Candiolo, Italy.
  • Muro XGD; Health Research Institute Fundación Jiménez Díaz (IIS-FJD, UAM), 28040 Madrid, Spain.
  • Trufero JM; Medical Oncology Department, University Hospital General de Villalba, 28400 Madrid, Spain.
  • Palmerini E; Medical Oncology Department, University Hospital Fundación Jiménez Díaz, 28040 Madrid, Spain.
  • García AS; Laboratory of Molecular Biology, Fundación Instituto Valenciano de Oncología, 46009 Valencia, Spain.
  • Bernabeu D; Catalan Institute of Oncology, Institut d'Investigació Biomédica de Bellvitge, University of Barcelona, 08907 Barcelona, Spain.
  • Le Cesne A; Department of Medical Oncology, University Hospital Miguel Servet, 50009 Zaragoza, Spain.
  • Casali PG; Chemotherapy Unit, Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.
  • Blay JY; Department of Medical Oncology, 08041 Sant Pau Hospital, Barcelona, Spain.
  • Cruz Jurado J; Musculoskeletal Imaging Section, University Hospital La Paz, 28046 Madrid, Spain.
  • Martin-Broto J; Department of Medical Oncology, Gustave Roussy Cancer Campus, 94805 Villejuif, France.
Cancers (Basel) ; 14(17)2022 Aug 29.
Article em En | MEDLINE | ID: mdl-36077723
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha